Transcatheter aortic valve replacement ( TAVI ) is an established treatment for inoperable patients or patients at high surgical risk with severe aortic stenosis. Herein, we illustrate the key design features of the main new generation devices that are entering contemporary clinical practice, the labeled and off‐labeled indications, the basic principles of screening process, and the clinical outcomes of the TAVI procedure. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193543/Activity.aspx
CITATION STYLE
Halapas, A., Chrissoheris, M., Bouboulis, N., Nicolaou, J., Pattakos, S., & Spargias, K. (2016). Update on current TAVI technology, indications, screening, and outcomes. Continuing Cardiology Education, 2(1), 37–46. https://doi.org/10.1002/cce2.20
Mendeley helps you to discover research relevant for your work.